TransMedics Group Inc (TMDX)
Working capital turnover
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 401,090 | 358,759 | 296,919 | 241,623 | 191,824 | 151,077 | 119,133 | 93,459 | 71,752 | 51,439 | 39,089 | 30,262 | 28,221 | 29,942 | 25,162 | 25,639 | 24,069 | 24,183 | 26,458 | 23,604 |
Total current assets | US$ in thousands | 492,475 | 509,265 | 488,306 | 510,654 | 536,724 | 662,655 | 261,730 | 252,294 | 250,586 | 95,113 | 105,795 | 118,705 | 125,577 | 135,052 | 140,543 | 146,766 | 154,126 | 158,227 | 91,704 | 100,001 |
Total current liabilities | US$ in thousands | 60,048 | 54,329 | 50,223 | 54,934 | 49,101 | 32,017 | 28,635 | 23,661 | 20,689 | 22,741 | 20,256 | 23,238 | 15,923 | 15,079 | 11,757 | 11,879 | 13,624 | 13,818 | 15,039 | 16,115 |
Working capital turnover | 0.93 | 0.79 | 0.68 | 0.53 | 0.39 | 0.24 | 0.51 | 0.41 | 0.31 | 0.71 | 0.46 | 0.32 | 0.26 | 0.25 | 0.20 | 0.19 | 0.17 | 0.17 | 0.35 | 0.28 |
September 30, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $401,090K ÷ ($492,475K – $60,048K)
= 0.93
TransMedics Group Inc's working capital turnover ratio has shown fluctuations over the past eight quarters, ranging from 0.17 to 0.93. The working capital turnover indicates how efficiently the company is utilizing its working capital to generate sales revenue. A higher ratio suggests that the company is effectively managing its working capital to support its operations and generate sales.
The trend in TransMedics Group Inc's working capital turnover ratio shows improvement over recent quarters, with a notable increase from 0.39 in December 2023 to 0.93 in September 2024. This indicates that the company has been able to more efficiently convert its working capital into sales revenue during this period.
However, it is important to note that the ratio fluctuated significantly in the past eight quarters, with some periods showing lower efficiency in working capital utilization. For example, the ratio dropped to 0.17 in March 2021 and then gradually improved before reaching its highest point in September 2024.
Overall, the trend in TransMedics Group Inc's working capital turnover ratio suggests a recent improvement in working capital management efficiency, but the company should continue monitoring this ratio to ensure consistent and optimal utilization of working capital resources.
Peer comparison
Sep 30, 2024